Generic and brand-name drugs. Are different criteria sufficiently taken into account before granting market authorisation?

Laroche, M L

Generic and brand-name drugs. Are different criteria sufficiently taken into account before granting market authorisation? [electronic resource] - Acta clinica Belgica 2006 - 48-50 p. digital

Publication Type: Comparative Study; Journal Article

1784-3286


Aged
Drug Approval
Drugs, Generic--adverse effects
Humans
Male
Parasympatholytics--adverse effects
Phenethylamines--adverse effects